These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348 [TBL] [Abstract][Full Text] [Related]
24. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799 [TBL] [Abstract][Full Text] [Related]
25. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569 [TBL] [Abstract][Full Text] [Related]
26. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669 [TBL] [Abstract][Full Text] [Related]
27. Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion. Wong CK; French JK; Krucoff MW; Gao W; Aylward PE; White HD Eur Heart J; 2002 Sep; 23(18):1449-55. PubMed ID: 12208225 [TBL] [Abstract][Full Text] [Related]
28. Unresolved issues in the thrombolytic treatment of myocardial infarction. Verstraete M Acta Cardiol; 1991; 46(5):517-26. PubMed ID: 1789046 [TBL] [Abstract][Full Text] [Related]
29. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. Jafri SM; Walters BL; Borzak S J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420 [TBL] [Abstract][Full Text] [Related]
30. Nonhemorrhagic complications of coronary thrombolysis. Johnstone D; Roy L Can J Cardiol; 1993; 9(6):511-5. PubMed ID: 8221345 [No Abstract] [Full Text] [Related]
31. Treatment of acute myocardial infarction: in which patients should primary percutaneous transluminal coronary angioplasty be preferred to thrombolysis? Topol EJ Cardiologia; 1996 Sep; 41(9):843-7. PubMed ID: 8940780 [No Abstract] [Full Text] [Related]
32. From the experimental myocardial infarction to the clinical acute myocardial infarction: limitations of thrombolytic therapy. Marzilli M Int J Cardiol; 1995 Aug; 49 Suppl():S71-5. PubMed ID: 7591319 [TBL] [Abstract][Full Text] [Related]
33. A review of the long term effects of thrombolytic agents. van Domburg RT; Boersma E; Simoons ML Drugs; 2000 Aug; 60(2):293-305. PubMed ID: 10983734 [TBL] [Abstract][Full Text] [Related]
34. The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials. Weaver WD Eur Heart J; 1996 Dec; 17 Suppl F():9-15. PubMed ID: 8960443 [TBL] [Abstract][Full Text] [Related]
35. Acute myocardial infarction-failed thrombolysis followed by severe upper gastrointestinal bleeding. Remskar M; Mozina H; Noc M; Zorman D; Stepec S Resuscitation; 1999 Aug; 41(3):282-3. PubMed ID: 10507717 [No Abstract] [Full Text] [Related]
36. Ridogrel as an adjunct to thrombolysis in acute myocardial infarction. van der Wieken LR; Simoons ML; Laarman GJ; Van den Brand M; Nijssen KM; Dellborg M; Hermens W; Vrolik W Int J Cardiol; 1995 Nov; 52(2):125-34. PubMed ID: 8749872 [TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings. Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835 [TBL] [Abstract][Full Text] [Related]
38. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction. Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648 [TBL] [Abstract][Full Text] [Related]
39. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction. Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590 [TBL] [Abstract][Full Text] [Related]